gip and glp 1 The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Dual GIP/GLP-1 receptor agonists: New
Description
doi: 10.2337/dc16-0691 [DOI] [PubMed] [Google Scholar] 58
For people without severe metabolic disease, this often comes down to personal preference
FTPP adipotide targets fat tissue vasculature
The pills are easier to store
This perception persisted despite extensive evidence that endogenous peptides regulate virtually every major physiological system, including metabolism, cardiovascular homeostasis, neuroendocrine signaling, immune modulation, and tissue repair
For other GLP-1 medications, follow product-specific guidance and your clinician's advice
